Target intelligence / Profile preview

Satiety induction via delayed gastric emptying

Molecular classification
Other (physiological process)
01

Overview

Satiety induction via delayed gastric emptying refers to the use of pharmacological or physiological mechanisms to slow the rate at which food leaves the stomach and enters the small intestine. This process increases feelings of fullness by prolonging stomach distension and enhancing signals from gut hormones such as cholecystokinin (CCK), glucagon-like peptide 1 (GLP‑1), and peptide YY (PYY) that communicate with the brain through neural pathways like the vagus nerve. These mechanisms are targeted therapeutically in obesity management—most notably by GLP‑1 receptor agonists—to reduce appetite and caloric intake. However, excessive delay can lead to symptoms such as nausea, vomiting, early satiety, bloating, nutritional deficiencies, and may contribute to conditions like gastroparesis.

Other names
Satiety induction via delayed gastric emptying
02

Mechanism of action

Delay of gastric emptying to prolong stomach distension and enhance satiety signaling via gut-brain axis\nActivation of gut peptide hormone pathways that inhibit gastric motility and promote fullness (e.g., GLP‑1, CCK)

03

Biological functions

Regulation of satietyControl of food intakeGastrointestinal motility
04

Disease associations

Obesity (as a therapeutic approach)Gastroparesis (as an adverse effect or disease state)Diabetes-related gastrointestinal dysfunction
05

Safety considerations

Risk of gastroparesis with excessive delay in gastric emptyingNausea and vomiting as common side effects with drugs that slow gastric emptyingNutritional deficiencies if chronic severe delay occurs
06

Interacting drugs

Glucagon-like peptide 1 receptor agonists (e.g., semaglutide, liraglutide)

2 more in the full profile.

07

Biomarkers

Gastric emptying rate (measured by scintigraphy or breath test)Plasma levels of GLP‑1, CCK, PYY after meal ingestion

Beyond the preview

Go deeper on Satiety induction via delayed gastric emptying.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Satiety induction via delayed gastric emptying.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call